Chargement en cours...
How to design preclinical studies in nanomedicine and cell therapy to maximize the prospects of clinical translation
The clinical translation of promising products, technologies and interventions from the disciplines of nanomedicine and cell therapy has been slow and inefficient. In part, translation has been hampered by suboptimal research practices that propagate biases and hinder reproducibility. These include...
Enregistré dans:
| Publié dans: | Nat Biomed Eng |
|---|---|
| Auteurs principaux: | , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
2018
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6436641/ https://ncbi.nlm.nih.gov/pubmed/30931172 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41551-018-0314-y |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|